These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30983794)

  • 1. Urinary N-acetyl-beta-d-glucosaminidase levels in diabetic adults.
    Omozee EB; Okaka EI; Edo AE; Obika LF
    J Lab Physicians; 2019; 11(1):1-4. PubMed ID: 30983794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary biomarker N-acetyl-β-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy.
    Sheira G; Noreldin N; Tamer A; Saad M
    J Diabetes Metab Disord; 2015; 14():4. PubMed ID: 25717442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
    Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
    Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy.
    Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
    Int J Clin Pract; 1997; 51(8):489-90. PubMed ID: 9536599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
    Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
    Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of urinary alanine aminopeptidase in the patients with diabetes mellitus-comparison among AAP microalbumin and N-acetyl-beta-D-glucosaminidase].
    Nakamura S
    Hokkaido Igaku Zasshi; 1991 Jul; 66(4):522-33. PubMed ID: 1680783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hyperfiltration on the measurement of urinary N-acetyl-beta-D-glucosaminidase.
    Müller D; Sievers E; Eggert P
    Pediatr Nephrol; 1999 Aug; 13(6):519-23. PubMed ID: 10452282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microalbumin and N-acetyl-beta-D-glucosaminidase in random spot urine samples as predictors of diabetic nephropathy in the elderly non-insulin dependent diabetic patients].
    Hirai M; Nakano H; Oba K; Metori S
    Nihon Ika Daigaku Zasshi; 1997 Dec; 64(6):518-25. PubMed ID: 9436372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Urinary N-Acetyl-Beta-D-Glucosaminidase and Microalbuminuria in Diabetic Black Africans.
    Udomah FP; Ekpenyong Ekrikpo U; Effa E; Salako B; Arije A; Kadiri S
    Int J Nephrol; 2012; 2012():235234. PubMed ID: 22966455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study.
    Navarro JF; Mora C; Muros M; Maca M; Garca J
    Am J Kidney Dis; 2003 Aug; 42(2):264-70. PubMed ID: 12900807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the Urinary N-acetyl-β-D-Glucosaminidase/Creatinine Ratio and Factors of the Metabolic Syndrome.
    Lee E; Lee YK; Kang HJ
    Ann Clin Lab Sci; 2018 Sep; 48(5):627-633. PubMed ID: 30373868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary N-acetyl beta glucosaminidase and gamma glutamyl transferase as early markers of diabetic nephropathy.
    Ambade V; Sing P; Somani BL; Basanna D
    Indian J Clin Biochem; 2006 Sep; 21(2):142-8. PubMed ID: 23105632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
    Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
    Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus.
    Asare-Anane H; Twum F; Kwaku Ofori E; Torgbor EL; Amanquah SD; Osafo C
    Dis Markers; 2016; 2016():2810639. PubMed ID: 27594733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of urinary N-acetyl-β-D-glucosaminidase combined with serum retinol-binding protein in early detection of diabetic nephropathy.
    Lin ZH; Dai SF; Zhao JN; Jiang Y
    World J Diabetes; 2023 Jun; 14(6):883-891. PubMed ID: 37383593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical availability of urinary N-acetyl-beta-D-glucosaminidase index in dogs with urinary diseases.
    Sato R; Soeta S; Miyazaki M; Syuto B; Sato J; Miyake Y; Yasuda J; Okada K; Naito Y
    J Vet Med Sci; 2002 Apr; 64(4):361-5. PubMed ID: 12014583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubular function and urinary N-acetyl-β-d-glucosaminidase and kidney injury molecule-1 levels in asthmatic children.
    Demir AD; Goknar N; Oktem F; Özkaya E; Yazıcı M; Torun E; Vehapoğlu A; Kucukkoc M
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):626-631. PubMed ID: 27272162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
    Minakami H
    Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus].
    Sánchez-Hueso MC; Mateo-Caãs J; Zamora-Madaria E
    An Med Interna; 1995 May; 12(5):216-20. PubMed ID: 7669872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.